Healthcare

Recent experience includes:

Intriva

Advised Intriva Capital on its acquisition of specialist care provider, Sequence Care Group.

Acadia Healthcare Company

Advised this US based provider of inpatient behavioural healthcare facilities on a US$662 million agreement to acquire Partnerships in Care and the £1.5 billion acquisition of Priory Group, a leading provider of behavioural healthcare facilities in the United Kingdom.

HC-One and Bupa

Advised HC-One on the £300 million acquisition of 122 care homes from Bupa, the international healthcare group.

NMC Health PLC

Advised NMC Health PLC on its acquisition of 100% of the issued share capital of HCN European Surgery Center Holdings limited, which owns 100% of Aspen healthcare Limited. Aspen operates a network of nine facilities across the country including four hospitals, three of which are based in the Greater London market (Parkside Hospital, The Holly Private Hospital and Highgate Hospital).

Clinical Outcomes

Advised the shareholders of Clinical Outcome Solutions, a global leader in clinical outcomes assessment research services, on the sale of the business to Validant.

HC-One and AXA

Advised HC-One on its arrangements with AXA to operate UK based care facilities on behalf of AXA Investment Managers – Real Assets. This was following AXA IM – Real Assets’ acquisition of the Retirement Villages Group.

Salutem Healthcare Limited

Advised Salutem Healthcare on its acquisitions of The Pathways Group, Modus Care, Clearwater Care, certain care home assets from Scope and New Century Care.

Nexus Tradeco Limited

Advised the property manager of Primary Health Properties plc on its £2.3 billion merger with Medicx fund, creating the UK’s largest healthcare real estate investment trust.

Angela Swift Holdings

Advised the sellers on the sale of their care home business to Methodist Homes Limited.

Archimedes Pharma

Advised the management and minority shareholders of this US based drug company on the buyout by Novo A/S of shares held by Warburg Pincus and drag along of minority shareholders.

Aspirations Care

Advised Elysian Capital on the secondary buyout of Aspirations Care, a specialist provider of supported living centres for adults with learning disabilities and complex needs.

Advanced Childcare

Advised on the acquisition and disposal of Advanced Childcare, a specialist provider of residential care, education and foster care to young people with behavioural, emotional and social difficulties.

Glenside

Advised on the acquisition of Glenside. Glenside provides specialist assessment, treatment and rehabilitation for adults with acute or long-term neurological conditions, including traumatic brain injury, through a complete range of rehabilitation services.

Kisimul

Advised on the acquisition and subsequent disposal of Kisimul, a long-established provider of quality education and care services to children and young adults with complex learning difficulties, challenging behaviour, autism and global developmental delay.

Good Care Group

Advised the Business Growth Fund on its investment in the live-in care provider The Good Care Group.

Patricia White’s

Advised the management team of care agencies Patricia White’s and Country Cousins on the acquisition of the companies by Limerston Capital from Saga plc.

Bowmark Capital

Advised Bowmark Capital on the £87 million disposal of CARE Fertility (CARE), a UK fertility clinic group for IVF treatment, to Silverfleet Capital.

Healthcare Homes

Advised the sellers on the sale of Healthcare Homes, the leading elderly residential care provider in East Anglia, to Omega Healthcare.

Blandford

Advised Blandford Capital on the acquisition of UK adult education and residential home provider, Hesley Group, from Antin Infrastructure Partners.

Ascenti

Advised Ascenti, a portfolio company of bd-capital, on its acquisition of Six Physio.

Apposite Capital LLP

Advised healthcare investor Apposite Capital on its investment in medical device company, Emblation.

Clinical Outcomes

Advised the shareholders of Clinical Outcome Solutions, a global leader in clinical outcomes assessment research services, on the sale of the business to Validant.

Bluecrest Health Screening

Advised the founders on the disposal of Bluecrest Health Screening Limited to Vespa Capital by way of a competitive auction process. Bluecrest is a private healthcare provider offering comprehensive health screening tests. This transaction provided an exit for the original seed investors of Bluecrest.

Health iQ

Advised the founders of Health iQ, a leading provider in real world data and digital solutions for healthcare and life sciences, on its sale by way of auction process to Corrona LLC, a US leader in real world evidence.